4-(2-Imidazolin-2-yl) aminopyrazoles

Drug – bio-affecting and body treating compositions – Live hair or scalp treating compositions – Shaving preparation

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548316, 548320, 548358, 260307F, 424 70, 424272, 424273P, C07D40312, A61K 715

Patent

active

041089820

ABSTRACT:
Physiologically-active and pharmaceutically-acceptable 4-aminopyrazoles of each of the formulae ##STR1## wherein each of R.sup.1, R.sup.2 and R.sup.3 is, independently, e.g., a hydrogen atom (--H), aliphatic hydrocarbyl, alicyclic hydrocarbyl, phenyl, substituted phenyl, phenalkyl or nuclearly-substituted phenalkyl.
And their pharmacologically-acceptable acid-addition salts are synthesized by known procedures from available starting materials or from compounds which are made by analogy procedures from known compounds. The subject 4-aminopyrazoles and their pharmacologically-acceptable acid-addition salts are prepared in the form of medicament compositions and used as diuretics, saluretics and/or antihypertensives.

REFERENCES:
patent: 3954757 (1976-05-01), Arya et al.
patent: 3979408 (1976-09-01), Trani
Pollak et al., Monatshefte fur Chemie 1972, vol. 103, pp. 1591-1603.
Verge et al., Chem. Abst. 1975, vol. 83, No. 10079k.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

4-(2-Imidazolin-2-yl) aminopyrazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-(2-Imidazolin-2-yl) aminopyrazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(2-Imidazolin-2-yl) aminopyrazoles will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1558498

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.